The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Humana Inc. shares fell after it lost a lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped the court would restore billions in revenue.

Humana Inc. shares fell after it lost a lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped the court would restore billions in revenue.

Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments.

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare Advantage plans.

By Nicholas G. Miller Humana lost its legal challenge to restore the quality ratings of its Medicare plans in a significant blow to future earnings potential.

Cologuard Classic will "make a couple tweaks to make the fan experience even better, but I think we have some good bones in place for the next three years" at hard-walking La Paloma Country Club.

Seen and head at the Cologuard Classic: Cologuard ambassador Jerry Kelly (shoulder) forced to withdraw; improving weather; "Chloe the Giant Colon"; and more.

Humana Inc (NYSE: HUM) has hit a 52-week low, with its stock price falling to 212.33 USD. This marks a significant downturn for the company, as it reflects a 42.31% decline over the past year.

Humana lost its legal challenge to restore the quality ratings of its Medicare plans in a significant blow to future earnings potential. A Texas district court ruled Friday against Humana, saying ...

Investing.com - Leerink Partners has reiterated its Market Perform rating and $271.00 price target on Humana (NYSE: HUM), currently trading near its 52-week low at $217, following the company’s ...